rss
J Med Genet doi:10.1136/jmg.2009.067512

OPA1 increases the risk of normal but not high tension glaucoma

  1. P Yu-Wai-Man (patrick.yu-wai-man{at}ncl.ac.uk)
  1. Mitochondrial Research Group, The Medical School, Newcastle University, United Kingdom
    1. J D Stewart (stewart{at}ifado.de)
    1. Mitochondrial Research Group, The Medical School, Newcastle University, United Kingdom
      1. G Hudson (gavin.hudson{at}ncl.ac.uk)
      1. Mitochondrial Research Group, The Medical School, Newcastle University, United Kingdom
        1. R M Andrews (richard.andrews{at}moorfields.nhs.uk)
        1. Moorfields Eye Hospital, United Kingdom
          1. P G Griffiths (p.g.griffiths{at}ncl.ac.uk)
          1. Department of Ophthalmology, Royal Victoria Infirmary, United Kingdom
            1. M K Birch (michael.birch{at}nuth.nhs.uk)
            1. Department of Ophthalmology, Royal Victoria Infirmary, United Kingdom
              1. P F Chinnery (p.f.chinnery{at}ncl.ac.uk)
              1. Mitochondrial Research Group, The Medical School, Newcastle University, United Kingdom
                • Published Online First 5 July 2009

                Abstract

                Background: Primary open angle glaucoma (POAG) is a progressive optic neuropathy characterised by the selective loss of retinal ganglion cells (RGCs), pathological optic disc cupping and visual field defects. The OPA1 gene encodes for an inner mitochondrial membrane protein crucial for normal mitochondrial function and pathogenic mutations cause autosomal dominant optic atrophy (DOA) by specifically targeting RGCs. This raises the distinct possibility that more subtle genetic variations in OPA1 could alter the risk of developing glaucoma.

                Methods: We studied 137 POAG patients, 67 patients with high tension glaucoma (HTG), 70 patients with normal tension glaucoma (NTG), and 75 controls from the North East of England. Three single nucleotide polymorphisms (SNPs) in intron 8 (IVS8+4c>t and IVS8+32t>c) and exon 4 (c.473A>G) of the OPA1 gene were genotyped in our study group. In addition, the entire OPA1 coding region was sequenced in 24 individuals with the CT/TT compound genotype using standard BigDyeTM chemistries.

                Results: There was no difference in either allele or genotype frequency for the IVS8+32t>c SNP between patients and controls, but there was a significant association between the T allele at IVS8+4c>t and the risk of developing NTG (Odds ratio (OR) = 2.04, 95% confidence interval (CI) = 1.10-3.81, P = 0.004), but not HTG. Logistic regression analysis also confirmed a strong association between the CT/TT compound genotype at IVS8+4 and IVS8+32 with NTG (OR = 29.75, 95% CI = 3.83-231.21, P = 0.001).

                Conclusions: The CT/TT compound genotype at IVS8+4 and IVS8+32 is a strong genetic risk determinant for NTG but not HTG.

                This Article

                1. Abstract
                2. PDF
                3. All versions of this article:
                  1. jmg.2009.067512v1
                  2. 47/2/120most recent

                Responses

                1. Submit a response
                2. No responses published

                Register for free content

                The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

                Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.